FDA Wants To Lengthen Review Time For Some Prior Approval Supplements

FDA wants to lengthen the goal for action on prior-approval manufacturing supplements as part of the PDUFA V reauthorization, but industry does not appear too willing to budge.

More from Archive

More from Pink Sheet